Inasmuch as the first phase-3 trial is expected to report data in 2015, MCUR ought to be able to raise cash on favorable terms if this trial is a success.
I own MCUR in the SI charity contest.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.